Karolinska Development
ISIN: SE0002190926 | Ticker: KDEV | LEI: 54930011ZA52NKO5W681
Country: Sweden
Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients’ lives and provide an attractive return on investment.
Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.
Karolinska Development has established a portfolio of 10 companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.
2003
HeadquartersTomtebodavägen 23a, 17165 Solna – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 890,083,000.00 | 1,109,275,000.00 | 1,251,646,000.00 |
| Noncurrent Assets | N/A | 771,010,000.00 | 1,012,659,000.00 | 1,044,222,000.00 |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss Designated Upon Initial Recognition | N/A | 770,320,000.00 | 950,170,000.00 | 983,995,000.00 |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss Mandatorily Measured At Fair Value | N/A | 0.00 | 61,799,000.00 | 59,537,000.00 |
| Current Assets | N/A | 119,073,000.00 | 96,616,000.00 | 207,424,000.00 |
| Trade And Other Current Receivables | N/A | 243,000.00 | 505,000.00 | N/A |
| Trade And Other Current Receivables Due From Related Parties | N/A | 80,000.00 | 505,000.00 | 211,000.00 |
| Current Prepaid Expenses | N/A | 929,000.00 | 2,940,000.00 | 750,000.00 |
| Other Current Receivables | N/A | 768,000.00 | 768,000.00 | 673,000.00 |
| Current Financial Assets At Fair Value Through Profit Or Loss Classified As Held For Trading | N/A | 0.00 | 50,005,000.00 | 58,742,000.00 |
| Cash and cash equivalents | 52,132,000.00 | 75,869,000.00 | 42,398,000.00 | 131,078,000.00 |
| Cash Equivalents | N/A | N/A | 42,398,000.00 | 131,078,000.00 |
| Equity And Liabilities | N/A | 890,083,000.00 | 1,109,275,000.00 | 1,251,646,000.00 |
| Equity | 1,007,754,000.00 | 800,267,000.00 | 971,086,000.00 | 1,241,438,000.00 |
| Issued Capital | N/A | 1,757,000.00 | 1,757,000.00 | 2,701,000.00 |
| Retained Earnings | N/A | -1,579,863,000.00 | -1,409,044,000.00 | -1,497,166,000.00 |
| Share Premium | N/A | 2,378,373,000.00 | 2,378,373,000.00 | 2,735,903,000.00 |
| Liabilities | N/A | 89,816,000.00 | 138,189,000.00 | 10,208,000.00 |
| Current Liabilities | N/A | 89,816,000.00 | 138,189,000.00 | 10,208,000.00 |
| Trade And Other Current Payables | N/A | 617,000.00 | 1,674,000.00 | 439,000.00 |
| Accruals Classified As Current | N/A | 5,525,000.00 | 7,268,000.00 | 8,171,000.00 |
| Other Current Financial Liabilities | N/A | 5,726,000.00 | 1,756,000.00 | 191,000.00 |
| Other Current Liabilities | N/A | 1,373,000.00 | 2,156,000.00 | 654,000.00 |
| Current Loans Received And Current Portion Of Noncurrent Loans Received | N/A | 75,864,000.00 | 124,603,000.00 | 0.00 |
| Line item in (sek) | 31.12.2019/ 01.01.2021 |
01.01.2020/ 01.01.2021 |
31.12.2020/ 01.01.2022 |
01.01.2021/ 01.01.2022 |
31.12.2021/ 01.01.2023 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|---|---|
| Revenue | N/A | 2,651,000.00 | N/A | 2,170,000.00 | N/A | 2,300,000.00 |
| Revenue From Interest | N/A | 908,000.00 | N/A | 6,406,000.00 | N/A | N/A |
| Interest Income On Loans And Receivables | N/A | N/A | N/A | 6,406,000.00 | N/A | 1,416,000.00 |
| Wages And Salaries | N/A | 23,620,000.00 | N/A | 23,205,000.00 | N/A | 26,585,000.00 |
| Depreciation And Amortisation Expense | N/A | 690,000.00 | N/A | 690,000.00 | N/A | 690,000.00 |
| Other Expense By Nature | N/A | 8,466,000.00 | N/A | 6,887,000.00 | N/A | 6,798,000.00 |
| Profit Loss From Operating Activities | N/A | -202,426,000.00 | N/A | 160,700,000.00 | N/A | -87,421,000.00 |
| Profit Loss Before Tax | N/A | -207,487,000.00 | N/A | 170,819,000.00 | N/A | -88,122,000.00 |
| Income Tax Expense Continuing Operations | N/A | 0.00 | N/A | 0.00 | N/A | 0.00 |
| Profit (loss) | -207,487,000.00 | -207,487,000.00 | 170,819,000.00 | 170,819,000.00 | -88,122,000.00 | -88,122,000.00 |
| Line item in (sek) | 01.01.2021 | 01.01.2020 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | -207,487,000.00 | N/A | 170,819,000.00 | -88,122,000.00 |
| Adjustments For Decrease Increase In Other Operating Receivables | 29,988,000.00 | N/A | -1,461,000.00 | 416,000.00 |
| Adjustments For Increase Decrease In Other Operating Payables | -33,708,000.00 | N/A | 46,084,000.00 | -1,661,000.00 |
| Adjustments For Depreciation And Amortisation Expense | 690,000.00 | N/A | 690,000.00 | 690,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 172,301,000.00 | N/A | -189,312,000.00 | 55,648,000.00 |
| Other Inflows Outflows Of Cash Classified As Operating Activities | -45,000.00 | N/A | 0.00 | -206,000.00 |
| Cash Flows From Used In Operating Activities | -33,200,000.00 | N/A | 16,701,000.00 | -32,534,000.00 |
| Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | 0.00 | N/A | 50,005,000.00 | 10,000,000.00 |
| Other Cash Receipts From Sales Of Interests In Joint Ventures Classified As Investing Activities | 101,853,000.00 | N/A | 56,427,000.00 | 0.00 |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | 39,154,000.00 | N/A | 52,759,000.00 | 109,166,000.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | -5,093,000.00 | N/A | -3,121,000.00 | 5,358,000.00 |
| Cash Flows From Used In Investing Activities | 57,606,000.00 | N/A | -49,458,000.00 | -113,808,000.00 |
| Proceeds From Issuing Shares | N/A | N/A | 0.00 | 254,911,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 669,000.00 | N/A | 714,000.00 | 714,000.00 |
| Cash Flows From Used In Financing Activities | -669,000.00 | N/A | -714,000.00 | 235,022,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 23,737,000.00 | N/A | -33,471,000.00 | 88,680,000.00 |
| Cash and cash equivalents | 75,869,000.00 | 52,132,000.00 | 42,398,000.00 | 131,078,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 04.05.23 | Johan Dighed | Other | Buy | SEK 56,350.00 |
| 27.03.23 | Johan Dighed | Other | Buy | SEK 89,000.00 |
| 17.02.23 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | SEK 72,100.00 |
| 19.12.22 | Johan Dighed | Other | Buy | SEK 83,500.00 |
| 30.09.22 | Johan Dighed | Other | Buy | SEK 72,336.60 |
| 26.06.20 | Hans Lennart Rudolf Wigzell | Other | Buy | SEK 25,780.04 |
| 26.06.20 | Hans Lennart Rudolf Wigzell | Other | Buy | SEK 14,350.00 |
| 24.06.20 | Hans Lennart Rudolf Wigzell | Other | Buy | SEK 26,529.36 |
| 24.06.20 | Hans Lennart Rudolf Wigzell | Other | Buy | SEK 13,331.15 |
| 23.06.20 | Hans Lennart Rudolf Wigzell | Other | Buy | SEK 111,562.62 |
SE0002190926
LEI54930011ZA52NKO5W681
SectorAsset Management & Custody Banks
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.